Stay updated on Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.
Latest updates to the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page
- Check2 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check53 days agoChange DetectedSeveral key resources related to pancreatic cancer and clinical trials have been removed, including links to MedlinePlus and NIH, which may impact access to important health information.SummaryDifference4%
- Check67 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to pancreatic cancer, including links to MedlinePlus and NIH, as well as new data fields for study information.SummaryDifference4%
- Check75 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.